Stockreport

Erasca Announces Proposed Public Offering of $150 Million of Common Stock

Erasca, Inc.  (ERAS) 
PDF SAN DIEGO, Jan. 20, 2026 (GLOBE NEWSWIRE) -- Erasca, Inc. (Nasdaq: ERAS), a clinical-stage precision oncology company singularly focused on discovering, developing, an [Read more]